➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Merck
AstraZeneca
Dow
Medtronic

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for GSI-136

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug GSI-136?

GSI-136 is an investigational drug.

There have been 11 clinical trials for GSI-136. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2002.

The most common disease conditions in clinical trials are Alzheimer Disease, Osteosarcoma, and Sarcoma, Synovial. The leading clinical trial sponsors are Wyeth is now a wholly owned subsidiary of Pfizer, National Cancer Institute (NCI), and Ohio State University.

Recent Clinical Trials for GSI-136
TitleSponsorPhase
Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based RegimenAzienda Ospedaliera San PaoloPhase 3
Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based RegimenCatholic University of the Sacred HeartPhase 3
Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based RegimenOspedale Amedeo di SavoiaPhase 3

See all GSI-136 clinical trials

Clinical Trial Summary for GSI-136

Top disease conditions for GSI-136
Top clinical trial sponsors for GSI-136

See all GSI-136 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Merck
AstraZeneca
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.